Cargos activos de Shlomo Lewkowicz
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Endobetix Ltd.
Endobetix Ltd. Medical SpecialtiesHealth Technology Endobetix Ltd. develops a nonsurgical implant that mimics the hormonal benefits offered by bariatric surgery. It offers Endobetix Bile Diversion Device which changes the hormonal balance and induces the release of key hormones such as GLP-1 to improve glucose tolerance and reduce fat absorption. The company was founded by Chen Porat, Pierre Sharvit, and Shlomo Lewkowicz in 2012 and is headquartered in Misgav, Israel. | Fundador | 01/01/2012 | - |
Corporate Officer/Principal | 01/01/2012 | - | |
HMT Medical Technologies Ltd.
HMT Medical Technologies Ltd. Medical SpecialtiesHealth Technology HMT Medical Technologies Ltd. has developed a novel device called "The Splitter" to enable safer and more effective aortic valve replacement procedures. The need for The Splitter arises from the fact that 1.5 million people suffer from aortic stenosis, a complex disease caused by a narrowing or hardening of the aortic valve due to calcium buildup on the heart valve flaps. The Israeli company was founded in 2021 and operates with a highly skilled team in interventional cardiology, medical device development, and commercialization. The CEO is Shlomo Lewkowicz. | Director Ejecutivo | - | - |
Historial de carrera de Shlomo Lewkowicz
Estadísticas
Internacional
Israel | 3 |
Operativa
Founder | 1 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Endobetix Ltd.
Endobetix Ltd. Medical SpecialtiesHealth Technology Endobetix Ltd. develops a nonsurgical implant that mimics the hormonal benefits offered by bariatric surgery. It offers Endobetix Bile Diversion Device which changes the hormonal balance and induces the release of key hormones such as GLP-1 to improve glucose tolerance and reduce fat absorption. The company was founded by Chen Porat, Pierre Sharvit, and Shlomo Lewkowicz in 2012 and is headquartered in Misgav, Israel. | Health Technology |
HMT Medical Technologies Ltd.
HMT Medical Technologies Ltd. Medical SpecialtiesHealth Technology HMT Medical Technologies Ltd. has developed a novel device called "The Splitter" to enable safer and more effective aortic valve replacement procedures. The need for The Splitter arises from the fact that 1.5 million people suffer from aortic stenosis, a complex disease caused by a narrowing or hardening of the aortic valve due to calcium buildup on the heart valve flaps. The Israeli company was founded in 2021 and operates with a highly skilled team in interventional cardiology, medical device development, and commercialization. The CEO is Shlomo Lewkowicz. | Health Technology |
- Bolsa de valores
- Insiders
- Shlomo Lewkowicz
- Experiencia